Key result
Synthetic peptide SP-26 immunization induces severe dose-dependent experimental autoimmune neuritis in rats.
Why the study?
The ability of a synthetic peptide corresponding to the 53-78 amino acid sequence of myelin P2 protein to induce severe experimental autoimmune neuritis in Lewis rats was investigated.
The synthetic peptide SP-26 can induce severe experimental autoimmune neuritis in Lewis rats, providing a model for studying autoimmune neuropathies.
Answers are grounded in this paper and cite their sources.
Provides a new peptide-based EAN model in rats; leaves open translation to human autoimmune neuropathies.
We generated a synthetic peptide (SP-26), corresponding to the amino acid residues 53-78 of bovine P2 protein, which induced severe clinical and pathological characteristics of experimental autoimmune neuritis (EAN) in Lewis rats. Lymph node cell populations from SP-26-immunized rats elicited a proliferative response to the peptide and to the P2 protein. After 16 cycles of antigen stimulation with the peptide, the SP-26 T cell line shows a decreased response to P2, but not to SP-26. Fluorescence-activated cell sorter (FACS) analysis of a SP-26 T cell line indicated the majority of cells to be of CD4+ CD8-. This report demonstrates that the synthetic peptide SP-26 can induce severe EAN in Lewis rats in a dose-dependent manner. Furthermore, specific T cell lines reactive to SP-26 can be generated from the lymph nodes of SP-26-immunized rats.
No takes yet. Share an insight, caveat, or question.
Rostami et al. (1990) studied Experimental autoimmune neuritis. Synthetic peptide SP-26 was evaluated on Induction of severe clinical and pathological characteristics of EAN. Immunization with the synthetic peptide SP-26 induced severe experimental autoimmune neuritis in Lewis rats in a dose-dependent manner.
Synapse has enriched 10 related papers. Consider them for comparative context: